Ioannis Gounaris
5PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 10, 2026
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors.Jatinder Kaur Mukker, Timothy A Yap, Anthony W Tolcher
|Jan 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis.Susanne A Gatz, Julia Glade-Bender, Andrew D J Pearson
|Aug 21, 2025
Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib.Jatinder Kaur Mukker, Paul Matthias Diderichsen, Farina Hellmann
|Feb 26, 2024
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors.Timothy A Yap, Anthony W Tolcher, Ruth Plummer
|Oct 11, 2023
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays.Danyi Wang, Brian Elenbaas, Karthikeyan Murugesan
Pageof 1
Frequent Collaborators
3 joint publications
Timothy A Yap
2 joint publications
Wei Gao
2 joint publications
Anthony W Tolcher
2 joint publications
Ruth Plummer
2 joint publications
Jatinder Kaur Mukker
2 joint publications
Rainer Strotmann
2 joint publications
Christine Hicking
2 joint publications
Paul Matthias Diderichsen
2 joint publications
Johann S de Bono
2 joint publications
Zoltan Szucs
